By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name Net Servicos de Comunicacao SA (ADR)
Stock ticker NETC
Live stock price [stckqut]NETC[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $21.04
Target stock price (averages with growth) $23.35
Target stock price (averages with no growth) $20.52
Target stock price (manual assumptions) $16.79

The following company description is from Google Finance: http://www.google.com/finance?q=netc
Net Servicos de Comunicacao S.A. (Net Servicos) is a multiservice company in the pay-television and broadband Internet industries in Brazil. As of December 31, 2009, the Company had 3.7 million pay-television connected subscribers in 93 locations in Brazil, including in Sao Paulo and Rio de Janeiro. It is a provider of high-speed cable modem Internet access in Brazil through its NET V?rtua service, which had 2.9 million subscribers as of December 31, 2009. Net Servicos also provides fixed line telephony through its NET Fone via Embratel service, which had 2.6 million subscribers as of December 31, 2009. As of December 31, 2009, its advanced network of coaxial and fiber-optic cable covered over 61,000 kilometers and passed approximately 10.8 million homes of which approximately 7.8 million belong to high and middle income classes and approximately 79% of such network had two-way communication capability.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name PNC Financial Services
Stock ticker PNC
Live stock price [stckqut]PNC[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $94.6
Target stock price (averages with growth) $114.13
Target stock price (averages with no growth) $94.01
Target stock price (manual assumptions) $71.48

“The PNC Financial Services Group, Inc. (PNC) is a diversified financial
service company. The Company is engaged in retail banking, corporate and
institutional banking, asset management, residential mortgage banking and
global investment servicing, providing many of its products and services
nationally and others in its primary geographic markets located in
Pennsylvania, Ohio, New Jersey, Michigan, Maryland, Illinois, Indiana,
Kentucky, Florida, Missouri, Virginia, Delaware, Washington, and Wisconsin.
It also provides certain investment servicing internationally. Retail
Banking provides deposit, lending, brokerage, trust, investment management,
and cash management services to consumer and small business customers within
its primary geographic markets. Asset Management Group includes personal
wealth management for high net-worth and ultra high net worth clients and
institutional asset management. BlackRock is an investment management firm. ”

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Old Stock Analysis, Stock analysis
Tagged:
With: 0 Comments
Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $125.89
Target stock price (averages with growth) $204.31
Target stock price (averages with no growth) $126.37
Target stock price (manual assumptions) $114.35

“Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company,
which is engaged in the discovery, development and commercialization of
biologic therapeutic products aimed at treating patients with severe and
life-threatening disease states, including hematologic, kidney and
neurologic diseases, transplant rejection, cancer and autoimmune disorders.
Its marketed product Soliris (eculizumab) is a therapy approved for the
treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In
April 2009 and August 2009, the United States food and drug administration
(FDA) and the European Commission (E.C.), respectively, granted Soliris
orphan drug designation for the treatment of patients with atypical
Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island
manufacturing facility received regulatory approval from the E.C. for the
production of Soliris. ”

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Old Stock Analysis, Stock analysis
Tagged:
With: 0 Comments
Company name IBERIABANK Corporation
Stock ticker IBKC
Live stock price [stckqut]IBKC[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $91
Target stock price (averages with growth) $118.3
Target stock price (averages with no growth) $95.77
Target stock price (manual assumptions) $73.4

“IBERIABANK Corporation (IBERIABANK) is a multi-bank financial holding
company with 209 combined offices, including 136 bank branch offices in
Louisiana, Arkansas, Florida, Alabama, Tennessee, and Texas, 26 title
insurance offices in Arkansas and Louisiana, and mortgage representatives in
47 locations in 12 states. The Company is the holding company for
IBERIABANK, a Louisiana banking corporation, Louisiana; IBERIABANK fsb, a
federal savings bank; Lenders Title Company, an Arkansas-chartered title
insurance and closing services agency and IBERIA Capital Partners LLC, a
corporate finance services firm in formation. The Company offers traditional
commercial bank products and services to its clients. These products and
services include a an array of commercial, consumer, mortgage, and private
banking products and services, cash management, deposit and annuity
products, and investment brokerage services. ”

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Old Stock Analysis, Stock analysis
Tagged:
With: 0 Comments
Company name Coach, Inc.
Stock ticker COH
Live stock price [stckqut]COH[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $74.97
Target stock price (averages with growth) $92.4
Target stock price (averages with no growth) $66.39
Target stock price (manual assumptions) $72.1

Confident Investor comments: I have reviewed Coach on this site before but they have improved the performance enough to be a Good Company. At this price and at this time, I think that a Confident Investor can confidently invest in this stock.